# Karyopharm Therapeutics Inc.: Form 8-K, filed Nov 8, 2024

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2024-11-08
- Accepted by EDGAR: Nov 8, 2024, 16:05 ET
- Period: 2024-11-05
- Accession: 0000950170-24-124067
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000095017024124067/kpti-20241105.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000095017024124067/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000095017024124067/kpti-20241105.htm

Filed Nov 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-124067. Last ingested by Listed: Nov 3, 2026, 06:05 ET. No prices; not investment advice.